4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-22-005596
Options or other derivatives
- Chief Financial Officer acquired 135,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Bellemin Jean-Marc Chief Financial Officer | 2022-01-14 | Grant or award · Stock Option (right to buy) | +135,000 | 135,000 | D | ||
Loading xslF345X03/tm223806-1_4seq1.xml…